Skip to main content
. 2013 Jun 24;13:288. doi: 10.1186/1471-2334-13-288

Table 3.

Studies reporting prevalence of hepatitis C virus among populations at direct or high risk of exposure in Egypt

Citation Year Location Sampling Population characteristic Sample size Sero-prevalence RNA prevalence
Viral hepatitis patients
El-Ahmady,94 [10]
N/A
Cairo city, Cairo
CS
 
51
25.5%
N/A
El-Gohary,94 [83]
N/A
Suez city, Suez
CS
 
140
19.2%
N/A
El Gaafary,05 [84]
2002
Cairo city, Cairo
CS
 
309
14.9%
N/A
Meky,06 [85]
2002-5
Nile River Delta, Lower Egypt
CS
 
47
78.7%
70.2%
Zakaria,07 [86]
2001-2
Giza, Upper Egypt
CS
 
200
13.0%
N/A
Kalil,10 [87]
2004-5
Assuit, Upper Egypt
CS
Children with viral hepatitis
150
8.7%
8.7%
Talaat,10 [88]
2001-4
Alexandria city, Alexandria/Abassia, Cairo/Mahalla, Gharbia, Lower Egypt/Qena and Aswan, Upper Egypt
CS
 
4,189
29.8%
N/A
Eldin,10 [89]
N/A
N/A
CS
 
235
4.3%
N/A
Badawy,12 [90]
N/A
Cairo city, Cairo
CS
Male military recruits with viral hepatitis
99
8%
N/A
Multi-transfused patients
Khalifa,93 [18]
1990-1
Cairo city, Cairo
CS
Multi-transfused children
84
55.0%
N/A
Abdel-Wahab,94 [53]
1992
Cairo city, Cairo
CS
Multi-transfused children
71
54.9%
N/A
Said,09 [91]
N/A
Cairo city, Cairo
CS
Multi-transfused children with hematological disorders
49
81.6%
49.0%
Said,09 [91]
N/A
Cairo city, Cairo
CS
Multi-transfused children with hematological malignancies
51
17.6%
23.5%
Salama,09 [78]
N/A
Cairo city, Cairo
CS
Multi-transfused children
33
15.2%
N/A
Kalil,10 [87]
2004-5
Assuit, Upper Egypt
CS
Multi-transfused children
165
58.2%
41.2%
Tonbary,10 [92]
2000-8
Mansoura, Dakahlia, Lower Egypt
CS
Multi-transfused children
72
11.1%
N/A
El-Faramawy,12 [93]
N/A
Qena, Upper Egypt
CS
Multi-transfused children
33
39%
N/A
Abdelwahab,12 [94]
N/A
Cairo city, Cairo
CS
Multi-transfused children
100
40%
N/A
Thalassemic patients
El-Nanawy,95 [19]
N/A
Alexandria city, Alexandria
CS
Children with thalassemia
18
44.4%
N/A
El Gohary,95 [36]
1990-2
Cairo city, Cairo
CS
Children with thalassemia
45
75.6%
N/A
Khalifa,04 [95]
2000-3
Cairo city, Cairo
CS
Children with thalassemia
56
69.6%
N/A
Abdalla,06 [96]
2005
Cairo city, Cairo / Banha, Qalubiya, Lower Egypt
CS
Children with thalassemia
33
60.6%
N/A
Omar,11 [97]
N/A
Cairo city, Cairo
CS
 
174
51.7%
32.2%
Mansour,12 [98]
2009-10
Mansoura, Dakahlia, Lower Egypt
CS
Children with thalassemia
200
19.5%
N/A
El-Faramawy,12 [93]
N/A
Qena, Upper Egypt
CS
Children with thalassemia
67
48%
N/A
Schistosomiasis patients
Bassily,92 [99]
N/A
Nile River Delta, Lower Egypt
CS
 
31
41.9%
N/A
El-Nanawy,95 [19]
N/A
Alexandria city, Alexandria
CS
 
21
38.1%
N/A
El-Zayadi,97 [39]
N/A
N/A
CS
 
320
16.3%
N/A
Zekri,02 [100]
1998-00
Cairo city, Cairo
CS
 
47
42.5%
N/A
Arafa,05 [62]
2002-3
Zawiat Razin, Menoufia, Lower Egypt
CS
Schistomiasis patients treated with PAT
206
51.5%
N/A
El-Sabah,11 [101]
N/A
Rural area, Cairo/ Gharbia, Lower Egypt
CS
Schistosomiasis patients treated with PAT
50
84.0%
N/A
El-Sabah,11 [101]
N/A
Rural area, Cairo/ Gharbia, Lower Egypt
CS
Schistosomiasis patients treated orally up to 8 years ago
52
7.7%
N/A
Hemodialysis patients
Hassan,93 [102]
N/A
N/A
CS
 
105
67.0%
N/A
Abdel-Wahab,94 [53]
1992
Cairo city, Cairo
CS
 
78
46.2%
N/A
El-Ahmady,94 [10]
N/A
Cairo city, Cairo
CS
 
25
84.0%
N/A
El Gohary,95 [36]
1990-2
Suez city, Suez and Ismailia, Lower Egypt
CS
 
108
70.4%
N/A
Gohar,95 [72]
N/A
N/A
CS
 
64
87.5%
N/A
Hassan,00 [103]
1996
Cairo city, Cairo
CS
 
210
59.0%
N/A
Shatat,00 [104]
1999
N/A
CS
 
83
78.5%
N/A
Gad,02 [105]
1998
Ismailia, Lower Egypt
CS
 
47
72.0%
N/A
Zekri,02 [100]
1998-00
Cairo city, Cairo
CS
 
30
56.6%
N/A
El Yazeed,06 [106]
2002-4
Cairo city, Cairo
CS
 
40
100.0%
N/A
Kandil,07 [22]
2004-6
Cairo city, Cairo
CS
 
31
51.6%
N/A
Hammad,09 [25]
2008
Mansoura, Dakahlia, Lower Egypt
CS
 
34
94.1%
N/A
Attia,10 [107]
2008-9
Cairo city, Cairo
CS
 
206
46.1%
N/A
Ibrahim,10 [108]
2007
Cairo city, Cairo
CS
 
100
75.0%
N/A
Injection Drug Users (IDUs)
El-Ghazzawi,95 [109] N/A Alexandria city, Alexandria CS   100 63.0% N/A

CS convenience sampling, N/A not available, PAT parenteral antischistosomiasis therapy.